Series B funding round for ImmPACT Bio raising $140M in January 2022
Series B funding round for ImmPACT Bio raising $140M in January 2022
| Investor | Firm Type | Partner |
|---|
Citadel LLCLEAD | Private | — |
NovartisLEAD | Private | — |
OrbiMedLEAD | Venture Capital | — |
Decheng CapitalLEAD | Venture Capital | — |
| Venture Capital | — |
Foresite CapitalLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$166M
Top Valuation
-
ImmPACT Bio raised $140M in a Series B round.
The round was announced on 01/01/22.
The round was led by Foresite Capital, OrbiMed, Bukwang Pharmaceutical, Min Cui, Novartis, RM Global Partners, Surveyor Capital.